Anu Research Centre, Department of Obstetrics and Gynaecology, University College Cork, Cork University Maternity Hospital, Cork, Republic of Ireland.
Ann Clin Biochem. 2014 Mar;51(Pt 2):277-83. doi: 10.1177/0004563213496394. Epub 2013 Sep 17.
Thyroid disorders are common in women of childbearing age and are associated with adverse pregnancy outcomes. Physiological changes in pregnancy and the lack of pregnancy-specific reference ranges make managing thyroid disorders in pregnancy challenging. Our aim was to establish trimester-specific thyroid function reference intervals throughout pregnancy, and to examine the prevalence of thyroid autoimmunity in otherwise euthyroid women.
This was a prospective, cross-sectional study of thyroid function tests (TFTs) in pregnant women attending a large, tertiary referral maternity hospital. Patients with known thyroid disorders, autoimmune disease, recurrent miscarriage, hyperemesis gravidarum and pre-eclampsia were excluded. TFTs were analysed in the CUH biochemistry laboratory using Roche Modular E170 electrochemiluminescent immunoassay. Trimester-specific reference ranges (2.5th, 50th and 97.5th centiles) were calculated.
Three-hundred-and-fifty-one women were included into the analysis. Median maternal age was 30. Thyroid-stimulating hormone concentrations showed slightly increasing median centile throughout gestation. Free thyroxine (T4) and T3 decreased throughout gestation. Table 1 demonstrates the calculated percentiles according to gestational weeks.
We established pregnancy-specific thyroid function reference intervals for our pregnant population, for use in clinical practice.
甲状腺疾病在育龄妇女中很常见,与不良妊娠结局有关。妊娠期间的生理变化和缺乏妊娠特异性参考范围使得妊娠期间甲状腺疾病的管理具有挑战性。我们的目的是建立整个妊娠期间特定于妊娠阶段的甲状腺功能参考区间,并检查甲状腺自身免疫在甲状腺功能正常的女性中的发生率。
这是一项在一家大型三级转诊妇产医院就诊的孕妇甲状腺功能检测(TFTs)的前瞻性、横断面研究。排除了已知甲状腺疾病、自身免疫性疾病、复发性流产、妊娠剧吐和子痫前期的患者。TFTs 在 CUH 生化实验室使用罗氏 Modular E170 电化学发光免疫分析法进行分析。计算了特定于妊娠阶段的参考范围(第 2.5、50 和 97.5 百分位)。
351 名妇女被纳入分析。产妇的中位年龄为 30 岁。促甲状腺激素浓度在整个妊娠期间呈略微升高的中位数趋势。游离甲状腺素(T4)和 T3 在整个妊娠期间下降。表 1 显示了根据妊娠周数计算的百分位数。
我们为我们的孕妇群体建立了妊娠特异性甲状腺功能参考区间,供临床实践使用。